Your session is about to expire
← Back to Search
Digital Personal Health Record for Multiple Chronic Conditions
N/A
Waitlist Available
Led By David Y Ming, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patient (age 18 or older) with MCC
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights
Study Summary
This trial will test a new app, called Caremap, to help coordinate care for patients with complex health needs. Up to 40 patients from Duke University will be enrolled.
Who is the study for?
This trial is for adult parents or guardians of children with special healthcare needs who have complex medical conditions requiring extra care coordination. Participants must be patients at Duke Pediatrics Primary Care or Duke Children's Cystic Fibrosis clinic, have an active online patient portal account, and own an Apple iOS device compatible with the Caremap app.Check my eligibility
What is being tested?
The study tests the Caremap app designed to improve care coordination for children with multiple chronic conditions. Up to 40 participants will use this mobile application and provide feedback on its effectiveness and usability in a real-world setting at Duke University.See study design
What are the potential side effects?
Since this trial involves a digital health record app rather than medication, traditional side effects are not applicable. However, users may experience technical issues or challenges using the app which can be reported as part of the study's feedback process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older with Merkel cell carcinoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in parent report of their child's health-related quality of life (HR-QOL), as measured by the PROMIS (7+2) Parent Proxy Global Health Survey
Change in patient-reported health-related quality of life (HR-QOL), as measured by the PROMIS Global Health Survey
Changes in perceptions of care integration as measured by Pediatric Integrated care survey (PICS)
+2 moreSecondary outcome measures
Adaptations made by families and providers during real-world use as measured by survey
Change in parent/caregiver self-management, as measured by the Parent-Patient Activation Measure (P-PAM)
Change in patient activation and ability to self manage chronic conditions, as measured by the Patient Activation Measure (PAM)
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Parent/CaregiversExperimental Treatment1 Intervention
Patient and parent/caregiver subjects from the participating clinic sites will be enrolled. These participants are all adults - parents or caregivers of children and youth with special health care needs (CYSHCN) and adult patients with multiple chronic conditions (MCC) who are already receiving care at Duke Health.
Group II: Clinical ProvidersExperimental Treatment1 Intervention
Clinical provider site champions will be invited to participate in web-based quantitative surveys and a semi-structured interview
Find a Location
Who is running the clinical trial?
Boston Children's HospitalOTHER
760 Previous Clinical Trials
5,579,613 Total Patients Enrolled
Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,002 Total Patients Enrolled
David Y Ming, MDPrincipal InvestigatorDuke Health
2 Previous Clinical Trials
60 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 or older with Merkel cell carcinoma.I am unable to make my own medical decisions due to a condition like advanced dementia.I am an adult and the legal guardian of a child with special health care needs.I am a parent/caregiver of a child with special health care needs.
Research Study Groups:
This trial has the following groups:- Group 1: Clinical Providers
- Group 2: Parent/Caregivers
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the overarching aims of this trial?
"This study is designed to ascertain the feasibility of implementation, as measured by the Feasibility Intervention Measure (FIM). Secondary objectives include evaluating Mobile app usability via System Usability Scale (SUS) scores provided by patients and parents/caregivers; measuring changes in adoption through quantitative data gathered from patient-side logins; and tracking clinician engagement with detailed records of dashboard views. The trial will run for six months and results evaluated at baseline, 3 month intervals, and 6 month intervals."
Answered by AI
Are there any remaining slots available for participants in this research?
"The data available on clinicaltrials.gov reveals that this medical trial, initially posted on September 1st 2022, is not currently recruiting patients. Even though recruitment has been halted presently, there are 24 other studies actively seeking participants at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger